Obesity Management
Dr Rajesh Jain MD Ex Medical officer-WHO Project Manager Diabetes Prevention Control Project, Uttar Pradesh, India National health Mission & World Diabetes foundation, Denmark
The Global Epidemic of Obesity
Obesity Is a Risk Factor for Many Comorbid Conditions
Life Expectancy Decreases as BMI Increases
Weight and Energy Balance: Current Perspective
Obesity: Imbalance of Energy Regulation
Feedback Regulation of Energy Metabolism
Phenotyping Patients With MHO: Key Clinical Parameters
Clinical and Functional Characteristics: MHO vs MUO
Weight Loss Improves Metabolic Risk Factors in Both Patients With MHO and Patients With MUO
Diabetes Prevention Program: Moderate Weight Loss Associated With Reduced Incidence of T2DM
Post-Hoc Analysis From Look AHEAD: The Importance of ≥10% Weight Loss
Look AHEAD: Intensive Lifestyle Intervention Associated With Reduced Incidence of Very High-Risk CKD
SCALE Obesity and Prediabetes Trial: Slower Onset to T2DM With Obesity Treatment
Weight Loss and Prevention of New Disease Onset: Results of the SOS Study
Weight Loss Strategies in Addition to Diet and Lifestyle Changes
Obesity Treatment Success: Percentage Body Weight Lost
Long-Term Anti-Obesity Drugs Approved in Europe and the US
Change in Weight From Baseline: Clinical Trial Data on 3 Drugs Approved by the EMA
Orlistat-Induced Weight Loss and Maintenance at 1 Year
COR-BMOD: Change in Body Weight, Naltrexone + Bupropion vs Placebo
SCALE: Change in Body Weight, Liraglutide vs Placebo
SCALE Maintenance: Patients Maintaining Run-In Weight Loss or Regaining ≥ 5%
The Conversation: Why Do You Eat The Conversation: Why Do You Eat? Stratifying Patients to Weight-Loss Agents
AACE/TOS/ASMBS Guidelines: Criteria for Bariatric Surgery Recommendation
Summary and Conclusions
Abbreviations
Abbreviations (cont)
Abbreviations (cont)